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1. Introduction Institutes of Allergy and Infectious Diseases, Bethesda, 
Md. Radiolabeling with rzsl was done as described [5]. 
Recent studies have provided significant insight into 
pathogenetically important molecular events in cholera. 
A bacterial exotoxin, which is the diarrhoeogenic agent, 
has been isolated and characterized chemically [l] . It 
is an antigenic, neutral protein with a molecular weight 
of 84 000 [?I constituting a multichain aggregate of 
at least two types of subunits [3]. It binds avidly to 
mammalian cell membranes [4,5], probably to G,l 
receptors [6-81. Cell-binding is followed by activation 
of adenylate cyclase which causes various effects in 
different cell types [9,10] 
2.2. Protein modification 
It is important to clarify how the structure of cho- 
lera toxin determines the antigenic, the receptor-bind- 
ing and the toxic properties. Recent studies by us have 
shown that one type of subunit, L, is responsible for 
the cell-binding and G,, g an g lioside-binding ability of 
the toxin and also for most of the antigenicity [3,5,6, 
111. The other subunit, H, is however, important for 
the biologic action and is also antigenic [3,5,11] . In 
the present study chemically-modified toxin deriva- 
tives have been prepared and investigated in an approach 
to characterize and perhaps differentiate between anti- 
genie, G,, -(receptor-)binding and toxic sites on 
cholera toxin. As a practical consequence, the work 
may serve as a guide in the search of a procedure for 
preparing a suitable toxoid for human immunization. 
Twenty commercially available reagents for amino 
acid residue specific modification of proteins were 
used. A 12 E.IM solution of cholera toxin in sterile Tris- 
EDTA buffer, pH 7.5 (0.01 M Tris, 0.0002 M Naz- 
EDTA, 0.0006 M NaNa and 0.04 M NaCl) was diluted 
1: 10 in buffer containing the protein modifying reagent. 
The buffer and incubation time and temperature varied 
for different reagents; for those reagents found to have 
the most interesting effects on cholera toxin the incu- 
bation conditions are reported in table 2, and a more 
detailed description of these and the other reagents 
will be published elsewhere [ 121 The reaction was 
stopped and the reactants separated by filtering the 
mixture through a small Sephadex G-l 5 gel column. 
The protein fraction was collected and diluted in Triss 
gelatin buffer, pH 7.5 (0.1 M Tris and 0.02%, w/v, 
gelatin) to a final concentration of 0.024 PM (2 pg/ 
ml) cholera protein. It was divided in small aliquots 
which were stored at -20°C until tested. 
For each reaction a control preparation was done, 
where cholera toxin was incubated under the appro- 
priate conditions but without any modifying reagent, 
and gel filtered as above. 
2.3. Enzymatic treatment 
2. Material and methods 
2.1. Cholera toxin 
Isolated cholera toxin prepared by R. A. Finkelstein, 
Dallas, Texas [l] , was obtained from the National 
Three enzymes bought from Sigma were studied for 
their influence on cholera toxin: leucine-aminopeptidase 
type III (86 U/mg) at a final incubation concentration 
of 0.67 mg/ml, carboxypeptidase-A DFP (47 U/mg) at 
7 mg/ml, and trypsin type III (100 U/mg) at 1 mg/ml. 
Each enzyme was incubated with 3.76 I.IM (0.33 mg/ml) 
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cholera toxin at 37°C for 4 hr in 0.1 M N-ethylmorphi- 
line-HCl, 0.001 M MgCl?, pH 8.4, with or without 
2 M urea. The reaction was stopped by 250-fold dilu- 
tion of the sample with 0.2 M ammonium formate, pH 
4.5, containing 0.2% gelatin (w/v). The sample was 
then immediately divided in small aliquots which were 
stored at -70°C until tested. Three types of controls 
were prepared: (i) a portion of the enzyme and toxin 
mixture taken at zero time: (ii) the enzyme and (iii) 
the toxin incubated separately under the same condi- 
tions as the test sample. 
2.4. Toxicity assay 
The toxic activity of the cholera toxin derivatives 
and their toxin control preparations was determined 
by testing multiple concentrations by the rabbit in- 
tradermal assay [ 131. The effect of the chemical modi- 
fication was evaluated by comparing the concentrations 
of test and control toxin preparations required for a 
blueing reaction of 7 mm in diameter (one blueing 
dose). 
2.5. Combined assay of GMr- and antibody-binding 
A technique, G,, - sorbent immunoassay, has recently 
been elaborated which measures a combination of the 
in vitro binding capacity of cholera toxin to polysty- 
rene-attached G,, g an g lioside and the ability of the 
bound toxin to bind subsequently added specific anti- 
body. The technique and the materials involved have 
been described [ 141. Evaluation of the influence of 
the chemical modification in this and in the two follow- 
ing methods was done in analogy with the toxicity 
assay, i.e. by comparing the concentrations of test and 
control toxin preparations required for a significant 
reaction. 
2.6. Assay of GMl-binding 
Pure G, ganglioside was attached to polystyrene 
test tubes as described [ 141. To the tubes was then 
added 0.25 ml of ‘251-labelled toxin (50 ng) in mixture 
with various concentrations of test or control toxin 
preparations. After incubation at 23°C for 2 hr, the ra- 
dioactivity of the washed tubes was determined. The 
ability of the tast and control toxin preparations to 
compete with the binding of ‘2SI-labelled toxin to 
GM I is a measure of their G, I-(receptor-)binding 
potency. 
2.7. Assay of antibody-binding 
The antibody-binding ability of the modified toxin 
preparations was tested by means of the ELISA-inhi- 
bition assay described previously [ 151. In principle, 
the ability of the test compared with the control toxin 
preparations to inhibit almost limiting dilution of 
antitoxin antiserum from binding to cholera toxin- 
coated polystyrene tubes is measured. 
3. Results 
The influence of the 20 protein-modifying amino 
acid specific reagents on the toxic, the GMI-(receptor-)- 
binding and antibody-fixing properties of cholera 
toxin was studied. Table 1 shows that ten reagents, in a 
final concentration of 1 mM, had no effect on effect of 
these properties, whereas seven reagents had a parallel 
destroying effect on both the toxicity and the com- 
bination of G M1 -binding and antibody-fixation. When 
G,, -binding and antibody-fixation were tested separa- 
tely for the toxin derivatives obtained with these 17 
reagents, a close but not complete association of the 
G,, -binding and the antigenic sites was found. These 
toxin regions were particularly sensitive to reagents 
which have specificity for amino groups. 
Three reagents had a differential effect on the 
toxicity and the combination of G,, -binding and 
antibody-fixation (table 1). These substances, which 
have a reported specificity for arginine residues, abo- 
lished the toxicity without causing any decrease of the 
G,, -binding ability (table 2). The antibody-binding 
capacity of the toxin also stayed intact, except after 
treatment with butandione when it was diminished 
(table 2). 
Table 1 
Influence on cholera toxin activities of 
protein-modifying amino acid specific reagents 
_ 
Effect on 
_~ _ 
Number of reagents Toxicity C+,,,l- and antibody- 
binding 
10 _ _ 
I + + 
3 + _ 
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Specification of reagents with differential effects on the toxic, G Ml-binding and antibody-fixing activities of cholera toxin 
Reagent Incubation conditions 
Effect on 
Specificity 
Toxicity GMl-binding Antibody-binding 
Cyclohexanedione 
Phenanthrenequinone 
Butandione 
1 mM in 0.05 M NaOH, arginine + _ _ 
23°C 1 hr 
1 mM in 0.05 M NaOH, 
5% ethanol, 23”C, 1 hr arginine + _ _ 
1 mM in phosphate pH 7.0, 
23°C 3 hr arginine + _ (+I 
Table 3 
Influence of specific proteolytic enzymes on cholera toxin activities 
Enzyme 
Effect on 
Toxicity G Ml-binding Antibody-binding 
Leucineaminopeptidase a) without urea _ _ _ 
b) with urea _ _ - 
Carboxypeptidase a) without urea _ _ _ 
b) with urea + _ _ 
Trypsin a) without urea - _ _ 
b) with urea + _ - 
We also tested the effect of treating cholera toxin 
with two exopeptidases, i.e. leucine-aminopeptidase and 
carboxypeptidase which digest proteins from the 
amino- and carboxyterminal ends respectively, and 
with the endopeptidase trypsin. Neither of these en- 
zymes had any influence even in high concentrations 
on the toxic or the GMI - and antibody fixing activities 
of the toxin when tested in ordinary buffers, but in 
the presence of 2 M urea effects were observed (table 
3). Both the carboxypeptidase and the endopeptidase 
abolished the toxicity but did not influence the GMI - 
and antibody-futing properties. 
All of the described results have been verified with 
at least one further batch of each toxin derivative. 
4. Discussion 
The results demonstrate that those protein-modi- 
fying reagents which decrease the ability of cholera 
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toxin to bind in vitro to the ganglioside GMI reduce 
the toxic activity correspondingly. This is natural in 
the light of the indicated function of the GMI gang- 
lioside as membrane receptor for the toxin in various 
target cells. However, the toxicity was also destroyed 
by a few reagents which did not reduce the GMI -bind- 
ing ability. This agrees with evidence obtained by 
other means [3,5] that for expression of toxic activity 
are required peptide regions additional to those in- 
volved in cell-binding. 
We have demonstrated that the L-type of subunit 
carries the G,, -binding as well as most of the antigenic 
properties of cholera toxin [ 1 l] . In this study, it is 
shown that there is a close but not absolute association 
between these activities. It is of considerable interest 
that specific reagents have been found which can 
abolish the toxicity completely without affecting the 
antigenicity of the toxin. This type of reagents may 
prove useful for developing toxoids for immunization 
against cholera. 
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